scPharmaceuticals Inc (SCPH)
4.74
-0.08
(-1.76%)
USD |
NASDAQ |
May 17, 16:00
4.74
0.00 (0.00%)
After-Hours: 20:00
scPharmaceuticals Revenue (Quarterly): 6.102M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.102M |
| December 31, 2023 | 6.096M |
| September 30, 2023 | 3.796M |
| Date | Value |
|---|---|
| June 30, 2023 | 1.638M |
| March 31, 2023 | 2.063M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.638M
Minimum
Jun 2023
6.102M
Maximum
Mar 2024
3.939M
Average
3.796M
Median
Sep 2023
Revenue (Quarterly) Benchmarks
| Anika Therapeutics Inc | 40.52M |
| Spero Therapeutics Inc | 4.204M |
| electroCore Inc | 5.443M |
| NovaBay Pharmaceuticals Inc | 2.631M |
| Palatin Technologies Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.11M |
| Total Expenses (Quarterly) | 21.96M |
| EPS Diluted (Quarterly) | -0.36 |
| Enterprise Value | 152.20M |
| Gross Profit Margin (Quarterly) | 70.75% |
| Profit Margin (Quarterly) | -231.2% |
| Earnings Yield | -31.16% |
| Normalized Earnings Yield | -31.16 |